-
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
NCT06728969 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT06926829 ·
Phase: Phase 3 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
NCT07087327 ·
Phase: Phase 3 ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
A Parent-child Yoga Intervention for Reducing Attention Deficits in Children with Congenital Heart Disease: a Feasibility Study
NCT05997680 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 4 Years to 6 Years ·
Sex: All (male and female) · 2 locations
-
A Pilot Study of a Remote ADHD Monitoring Program
NCT06743425 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 5 Years to 11 Years ·
Sex: All (male and female) · 2 locations
-
A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD
NCT07242625 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 5 Years to 12 Years ·
Sex: All (male and female) · 3 locations
-
A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
NCT07552909 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 11 Years ·
Sex: All (male and female) · 1 location
-
A Study on the Preference of Risperidone Dosage Forms
NCT06657430 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
NCT07755410 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
NCT07380412 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
NCT07759154 ·
Phase: Phase 3 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 16 locations
-
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
NCT06299189 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
NCT06248229 ·
Phase: Phase 4 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
NCT07086313 ·
Phase: Phase 2, Phase 3 ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence
NCT07456631 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
ADHD PreSMA Response Inhibition Therapy
NCT06325813 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes
NCT07228650 ·
Phase: Not specified ·
Ages: 16 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
ADHD&me: Targeting Self-esteem in Youth With ADHD
NCT07504107 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 16 Years to 25 Years ·
Sex: All (male and female) · 1 location
-
ADOLESCENTS IMAGING USING fMRI: Feasibility Study
NCT07540429 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 17 Years ·
Sex: Female · 1 location
-
ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder
NCT07478458 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 13 Years to 18 Years ·
Sex: All (male and female) · 2 locations
-
AWARE: Management of ADHD in Autism Spectrum Disorder
NCT05916339 ·
Phase: Phase 4 ·
Ages: 4 Years to 17 Years ·
Sex: All (male and female) · 12 locations
-
Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD
NCT07219810 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children
NCT03425669 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 9 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.
NCT06860763 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 12 Years ·
Sex: All (male and female) · 1 location
-
Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
NCT06971640 ·
Phase: Not specified ·
Ages: 6 Years to 9 Years ·
Sex: All (male and female) · 1 location
-
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
NCT07329673 ·
Phase: Not specified ·
Ages: 6 Years to 60 Years ·
Sex: All (male and female) · 1 location
-
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
NCT06685601 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 18 Years ·
Sex: All (male and female) · 2 locations
-
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
NCT06577779 ·
Phase: Phase 4 ·
Ages: 18 Years to 60 Years ·
Sex: All (male and female) · 1 location
-
Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders
NCT07273695 ·
Phase: Not specified ·
Ages: 8 Years to 15 Years ·
Sex: All (male and female) · 1 location
-
Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Years
NCT06764810 ·
Phase: Not specified ·
Ages: 4 Years to 11 Years ·
Sex: All (male and female) · 1 location
-
Atomoxetine and Executive Function in PTSD
NCT06573970 ·
Phase: Phase 4 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Attention Deficit Hyperactivity Disorder
NCT06232226 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 99 Years ·
Sex: All (male and female) · 3 locations
-
Attention Modulation of Local and Global Inhibition Mechanisms
NCT04279158 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors
NCT07469215 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 5 Years to 12 Years ·
Sex: All (male and female) · 1 location
-
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
NCT06978452 ·
Phase: Not specified ·
Ages: 9 Years to 25 Years ·
Sex: All (male and female) · 1 location
-
Benefits of ADHD Treatment in Detained People
NCT05842330 ·
Phase: Phase 3 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Big Feelings: A Study on Children's Emotions in Therapy
NCT05637320 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 15 Years ·
Sex: All (male and female) · 2 locations
-
Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
NCT07793045 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Biomarker Research in Inherited Movement Disorders
NCT05034172 ·
Phase: Not specified ·
Ages: 7 Years and older ·
Sex: All (male and female) · 1 location
-
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
NCT04421248 ·
Phase: Phase 4 ·
Ages: 8 Years to 12 Years ·
Sex: All (male and female) · 2 locations
-
Brain Imaging in Babies Study
NCT04443179 ·
Phase: Not specified ·
Ages: 16 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
CFT-focused Mental Health Intervention With Exposure Training for Youngsters
NCT05802758 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 15 Years to 20 Years ·
Sex: Male · 2 locations
-
Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)
NCT07592390 ·
Phase: Phase 1, Phase 2 ·
Ages: 12 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NCT03781752 ·
Phase: Phase 4 ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 4 locations
-
Central Executive Training and Parent Training for ADHD
NCT05492422 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 12 Years ·
Sex: All (male and female) · 1 location
-
Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery
NCT07439276 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 16 Years ·
Sex: All (male and female) · 1 location
-
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT04704687 ·
Phase: Phase 3 ·
Ages: 7 Years to 14 Years ·
Sex: All (male and female) · 1 location
-
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
NCT06967857 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
NCT02812537 ·
Phase: Not specified ·
Ages: Up to 16 Years ·
Sex: All (male and female) · 1 location
-
Cognitive Disengagement Syndrome in Functional Neurological Symptom Disorder
NCT07451821 ·
Phase: Not specified ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
Cognitive Remediation in Forensic Mental Health Care
NCT04610697 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
NCT07281092 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 13 Years to 17 Years ·
Sex: All (male and female) · 2 locations
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
NCT07089745 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 13 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Daily Routines, Executive Functioning & ADHD
NCT06682949 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 11 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment
NCT06858527 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Developing Brain, Impulsivity and Compulsivity
NCT04631042 ·
Phase: Not specified ·
Ages: 6 Years to 80 Years ·
Sex: All (male and female) · 1 location
-
Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
NCT06848959 ·
Phase: Not specified ·
Ages: 2 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
NCT05608434 ·
Phase: Phase 1, Phase 2 ·
Ages: 8 Years to 16 Years ·
Sex: All (male and female) · 1 location
-
Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)
NCT06410495 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Digital Health Intervention for Children With ADHD
NCT06456372 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 12 Years ·
Sex: All (male and female) · 2 locations
-
Dual Executive Function Training Package
NCT07262853 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 11 Years ·
Sex: All (male and female) · 1 location
-
Dual-target iTBS for Youth With ADHD
NCT07084649 ·
Phase: Phase 1, Phase 2 ·
Ages: 10 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
NCT05832489 ·
Phase: Phase 3 ·
Ages: 18 Years to 60 Years ·
Sex: All (male and female) · 1 location
-
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
NCT04144439 ·
Phase: Phase 4 ·
Ages: 4 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children
NCT07665658 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 12 Years ·
Sex: All (male and female) · 1 location
-
Effects and Mechanisms of Transcranial Direct Current Stimulation Combined With Dialectical Behavior Therapy Skills Training in Adults With Attention-Deficit/Hyperactivity Disorder
NCT07565402 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD
NCT06632249 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 17 Years ·
Sex: All (male and female) · 2 locations
-
Effects of Probiotics on the Gut-brain Axis in Children
NCT07459699 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 11 Years ·
Sex: All (male and female) · 1 location
-
Effects of Transcranial Photobiomodulation in ADHD
NCT07203092 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 44 Years ·
Sex: All (male and female) · 1 location
-
Effects of an Aerobic Exercise Intervention on Core Symptoms, Executive Functioning, and Quality of Life in Children With Attention Deficit Hyperactivity Disorder
NCT06553430 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 14 Years ·
Sex: All (male and female) · 1 location
-
Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
NCT05133804 ·
Phase: Phase 2 ·
Ages: 20 Years to 60 Years ·
Sex: All (male and female) · 3 locations
-
Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD
NCT06194994 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 6 Years to 12 Years ·
Sex: All (male and female) · 1 location
-
Encouraging Positive Parenting Habits
NCT06305429 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 4 Years to 10 Years ·
Sex: All (male and female) · 1 location
-
Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD
NCT06180681 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 11 Years ·
Sex: All (male and female) · 1 location
-
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
NCT07389473 ·
Phase: Not specified ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD
NCT07614867 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
NCT07784348 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 4 Years to 8 Years ·
Sex: All (male and female) · 1 location
-
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
NCT04781140 ·
Phase: Phase 4 ·
Ages: 48 Months to 69 Months ·
Sex: All (male and female) · 47 locations
-
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
NCT05935722 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: No age limits stated ·
Sex: All (male and female) · 5 locations
-
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
NCT06931080 ·
Phase: Phase 2, Phase 3 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Evaluation of the Invest in Play Program - a New Parent Intervention for Children With Problem Behavior
NCT06984809 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 5 locations
-
Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System (ANS) Functions in Children and Adolescents With ADHD
NCT07634809 ·
Phase: Not specified ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD
NCT06810180 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 12 Years ·
Sex: All (male and female) · 2 locations
-
Executive Function Training for Children and Adolescents
NCT07147894 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Executive Function and Parenting in Childhood
NCT06241300 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 4 Years and older ·
Sex: All (male and female) · 1 location
-
Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder
NCT07001293 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Female · 1 location
-
Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients
NCT06910605 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 10 Years and older ·
Sex: All (male and female) · 1 location
-
External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial
NCT06655610 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
NCT07214545 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 14 Years ·
Sex: All (male and female) · 1 location
-
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NCT05099874 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 16 Years ·
Sex: All (male and female) · 1 location
-
Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
NCT06797726 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 3 locations
-
Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
NCT07327775 ·
Phase: Not specified ·
Ages: 18 Years to 50 Years ·
Sex: Female · 1 location
-
Fidgeting and Attentional and Emotional Regulation in ADHD
NCT04526600 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 30 Years ·
Sex: All (male and female) · 1 location
-
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
NCT04532190 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 9 Years to 15 Years ·
Sex: All (male and female) · 1 location
-
Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
NCT07531914 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Focus Groups in Ethnically and Racially Diverse Families
NCT05930886 ·
Phase: Not specified ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female) · 1 location
-
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
NCT07717879 ·
Phase: Phase 3 ·
Ages: 6 Years to 11 Years ·
Sex: All (male and female) · 23 locations
-
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
NCT07717892 ·
Phase: Phase 3 ·
Ages: 12 Years to 17 Years ·
Sex: All (male and female) · 24 locations
-
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
NCT05354232 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
NCT07256704 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
Trials recruiting for ADHD often also study these conditions. Each links to its own recruiting-trial list.
Study-related care in a clinical trial is usually provided at no cost to participants, and
some trials reimburse travel. Costs vary by study - the trial team will explain what is and
is not covered. Confirm this directly with them.
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and
sex only. The full eligibility (your medical history, current medications, test results) is
assessed by the study team. Open any trial to read its criteria, then contact the site.